Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
Introduction To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
[引用][C] Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta …
EJ Lehrer, AU Kishan, BY James, DM Trifiletti… - Radiotherapy and …, 2020 - cir.nii.ac.jp
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation
therapy for localized prostate cancer: A systematic review and meta-analysis of phase III …
therapy for localized prostate cancer: A systematic review and meta-analysis of phase III …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
EJ Lehrer, AU Kishan, BY James… - Radiotherapy and …, 2020 - thegreenjournal.com
Introduction To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
EJ Lehrer, AU Kishan, BY James… - Radiotherapy and …, 2020 - pure.psu.edu
Introduction: To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
EJ Lehrer, AU Kishan, BY James… - Radiotherapy and …, 2020 - mayoclinic.elsevierpure.com
Introduction: To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
EJ Lehrer, AU Kishan, JB Yu, DM Trifiletti… - … Oncology: Journal of …, 2020 - europepmc.org
Methods A PICOS/PRISMA/MOOSE protocol was used to identify eligible studies. Weighted
random effects meta-analyses were conducted using the DerSimonian and Laird method …
random effects meta-analyses were conducted using the DerSimonian and Laird method …
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis …
EJ Lehrer, AU Kishan, BY James… - … : journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction To characterize the efficacy (5-year disease-free survival [DFS]) and safety
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …
(incidence of grade 2+ late gastrointestinal or genitourinary toxicity) of ultrahypofractionated …